Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 2, 2013, Pages 354-361

  Shami, Annelie ^a   Gustafsson, Renata ^a   Kalamajski, Sebastian ^a   Krams, Rob ^b   Segers, Dolf ^c   Rauch, Uwe ^a   Roos, Gunnel ^a   Nilsson, Jan ^d   Oldberg, Åke ^a   Hultgårdh Nilsson, Anna ^a  

^a LUND UNIVERSITY   (Sweden)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d LUND UNIVERSITY   (Sweden)

Author keywords

atherosclerosis; carotid arteries; collagen; fibromodulin; LDL

Indexed keywords

APOLIPOPROTEIN E; COLLAGEN FIBRIL; FIBROMODULIN; INTERLEUKIN 10; INTERLEUKIN 6; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA ROOT; ARTERY LESION; ARTERY MUSCLE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CELL CULTURE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ELECTRON MICROSCOPY; EXTRACELLULAR MATRIX; FEMALE; GENETIC HETEROGENEITY; HISTOPATHOLOGY; LIPID STORAGE; MACROPHAGE; MOUSE; NONHUMAN; OSCILLATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SHEAR STRESS; SMOOTH MUSCLE FIBER;

ANIMALS; AORTA; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CELL LINE; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EXTRACELLULAR MATRIX PROTEINS; FIBRILLAR COLLAGENS; GENOTYPE; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; PROTEOGLYCANS; REGIONAL BLOOD FLOW; STRESS, MECHANICAL;

EID: 84872893409     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300723     Document Type: Article

References (45)

1. Adiguzel E, Ahmad PJ, Franco C, Bendeck MP. Collagens in the progression and complications of atherosclerosis. Vasc Med. 2009;14:73-89.
2. Hansson GK. Infammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
3. Katsuda S, Okada Y, Minamoto T, Oda Y, Matsui Y, Nakanishi I. Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specifc antibodies. Arterioscler Thromb. 1992;12:494-502.
4. Koyama H, Raines EW, Bornfeldt KE, Roberts JM, Ross R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell. 1996;87:1069-1078.
5. Li S, Lao J, Chen BP, Li YS, Zhao Y, Chu J, Chen KD, Tsou TC, Peck K, Chien S. Genomic analysis of smooth muscle cells in 3-dimensional collagen matrix. FASEB J. 2003;17:97-99.
6. Ichii T, Koyama H, Tanaka S, Kim S, Shioi A, Okuno Y, Raines EW, Iwao H, Otani S, Nishizawa Y. Fibrillar collagen specifcally regulates human vascular smooth muscle cell genes involved in cellular responses and the pericellular matrix environment. Circ Res. 2001;88:460-467.
7. Tanner FC, Yang ZY, Duckers E, Gordon D, Nabel GJ, Nabel EG. Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res. 1998;82:396-403.
8. Lepidi S, Kenagy RD, Raines EW, Chiu ES, Chait A, Ross R, Clowes AW. MMP9 production by human monocyte-derived macrophages is decreased on polymerized type I collagen. J Vasc Surg. 2001;34:1111-1118.
9. Kaplan G, Gaudernack G. In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen. J Exp Med. 1982;156:1101-1114.
10. Wesley RB II, Meng X, Godin D, Galis ZS. Extracellular matrix modulates macrophage functions characteristic to atheroma: collagen type I enhances acquisition of resident macrophage traits by human peripheral blood monocytes in vitro. Arterioscler Thromb Vasc Biol. 1998;18:432-440.
11. McEwan PA, Scott PG, Bishop PN, Bella J. Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans. J Struct Biol. 2006;155:294-305.
12. Kalamajski S, Oldberg A. The role of small leucine-rich proteoglycans in collagen fbrillogenesis. Matrix Biol. 2010;29:248-253.
13. Oldberg A, Antonsson P, Lindblom K, Heinegård D. A collagen-binding 59-kd protein (fbromodulin) is structurally related to the small interstitial proteoglycans PG-S1 and PG-S2 (decorin). EMBO J. 1989;8:2601-2604.
14. Heinegård D, Larsson T, Sommarin Y, Franzén A, Paulsson M, Hedbom E. Two novel matrix proteins isolated from articular cartilage show wide distributions among connective tissues. J Biol Chem. 1986;261:13866-13872.
15. Chakravarti S. Functions of lumican and fbromodulin: lessons from knockout mice. Glycoconj J. 2002;19:287-293.
16. Kalamajski S, Oldberg A. Fibromodulin binds collagen type I via Glu-353 and Lys-355 in leucine-rich repeat 11. J Biol Chem. 2007;282:26740-26745.
17. Ezura Y, Chakravarti S, Oldberg A, Chervoneva I, Birk DE. Differential expression of lumican and fbromodulin regulate collagen fbrillogenesis in developing mouse tendons. J Cell Biol. 2000;151:779-788.
18. Svensson L, Aszódi A, Reinholt FP, Fässler R, Heinegård D, Oldberg A. Fibromodulin-null mice have abnormal collagen fbrils, tissue organization, and altered lumican deposition in tendon. J Biol Chem. 1999;274:9636-9647.
19. Ameye L, Aria D, Jepsen K, Oldberg A, Xu T, Young MF. Abnormal collagen fbrils in tendons of biglycan/fbromodulin-defcient mice lead to gait impairment, ectopic ossifcation, and osteoarthritis. FASEB J. 2002;16:673-680.
20. Khorasani H, Zheng Z, Nguyen C, Zara J, Zhang X, Wang J, Ting K, Soo C. A quantitative approach to scar analysis. Am J Pathol. 2011;178:621-628.
21. Mormone E, Lu Y, Ge X, Fiel MI, Nieto N. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fbrogenic response to liver injury in mice. Gastroenterology. 2012;142:612-621.e5.
22. Oldberg A, Kalamajski S, Salnikov AV, Stuhr L, Mörgelin M, Reed RK, Heldin NE, Rubin K. Collagen-binding proteoglycan fbromodulin can determine stroma matrix structure and fuid balance in experimental carcinoma. Proc Natl Acad Sci USA. 2007;104:13966-13971.
23. Cheng C, Tempel D, van Haperen R, van der Baan A, Grosveld F, Daemen MJ, Krams R, de Crom R. Atherosclerotic lesion size and vulnerability are determined by patterns of fuid shear stress. Circulation. 2006;113:2744-2753.
24. Hultgårdh-Nilsson A, Lövdahl C, Blomgren K, Kallin B, Thyberg J. Expression of phenotype-and proliferation-related genes in rat aortic smooth muscle cells in primary culture. Cardiovasc Res. 1997;34:418-430.
25. Tran-Lundmark K, Tran PK, Paulsson-Berne G, Fridén V, Soininen R, Tryggvason K, Wight TN, Kinsella MG, Borén J, Hedin U. Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation. Circ Res. 2008;103:43-52.
26. Ström A, Ahlqvist E, Franzén A, Heinegård D, Hultgårdh-Nilsson A. Extracellular matrix components in atherosclerotic arteries of Apo E/LDL receptor defcient mice: an immunohistochemical study. Histol Histopathol. 2004;19:337-347.
27. Falk E. Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. Am J Cardiol. 1989;63:114E-120E.
28. Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res. 2008;79:360-376.
29. Frisdal E, Lesnik P, Olivier M, Robillard P, Chapman MJ, Huby T, Guerin M, Le Goff W. Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinfammatory response. J Biol Chem. 2011;286:30926-30936.
30. Lucero HA, Kagan HM. Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell Mol Life Sci. 2006;63:2304-2316.
31. Engelholm LH, Ingvarsen S, Jürgensen HJ, Hillig T, Madsen DH, Nielsen BS, Behrendt N. The collagen receptor uPARAP/Endo180. Front Biosci. 2009;14:2103-2114.
32. Hedbom E, Heinegård D. Binding of fbromodulin and decorin to separate sites on fbrillar collagens. J Biol Chem. 1993;268:27307-27312.
33. Chen S, Oldberg A, Chakravarti S, Birk DE. Fibromodulin regulates collagen fbrillogenesis during peripheral corneal development. Dev Dyn. 2010;239:844-854.
34. Gill MR, Oldberg A, Reinholt FP. Fibromodulin-null murine knee joints display increased incidences of osteoarthritis and alterations in tissue biochemistry. Osteoarthr Cartil. 2002;10:751-757.
35. Zheng Z, Nguyen C, Zhang X, Khorasani H, Wang JZ, Zara JN, Chu F, Yin W, Pang S, Le A, Ting K, Soo C. Delayed wound closure in fbromodulin-defcient mice is associated with increased TGF-β3 signaling. J Invest Dermatol. 2011;131:769-778.
36. Namiki M, Kawashima S, Yamashita T, Ozaki M, Sakoda T, Inoue N, Hirata K, Morishita R, Kaneda Y, Yokoyama M. Intramuscular gene transfer of interleukin-10 cDNA reduces atherosclerosis in apolipopro-tein E-knockout mice. Atherosclerosis. 2004;172:21-29.
37. Caligiuri G, Rudling M, Ollivier V, Jacob MP, Michel JB, Hansson GK, Nicoletti A. Interleukin-10 defciency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med. 2003;9:10-17.
38. Tillgren V, Onnerfjord P, Haglund L, Heinegård D. The tyrosine sulfate-rich domains of the LRR proteins fbromodulin and osteoadherin bind motifs of basic clusters in a variety of heparin-binding proteins, including bioactive factors. J Biol Chem. 2009;284:28543-28553.
39. Kaplan M, Aviram M. Retention of oxidized LDL by extracellular matrix proteoglycans leads to its uptake by macrophages: an alternative approach to study lipoproteins cellular uptake. Arterioscler Thromb Vasc Biol. 2001;21:386-393.
40. Van Doormaal MA, Kazakidi A, Wylezinska M, Hunt A, Tremoleda JL, Protti A, Bohraus Y, Gsell W, Weinberg PD, Ethier CR. Haemodynamics in the mouse aortic arch computed from MRI-derived velocities at the aortic root. J R Soc Interface. 2012;9:2834-2844.
41. Ranjzad P, Salem HK, Kingston PA. Adenovirus-mediated gene transfer of fbromodulin inhibits neointimal hyperplasia in an organ culture model of human saphenous vein graft disease. Gene Ther. 2009;16:1154-1162.
42. Adiguzel E, Hou G, Mulholland D, Hopfer U, Fukai N, Olsen B, Bendeck M. Migration and growth are attenuated in vascular smooth muscle cells with type VIII collagen-null alleles. Arterioscler Thromb Vasc Biol. 2006;26:56-61.
43. Vogel WF, Abdulhussein R, Ford CE. Sensing extracellular matrix: an update on discoidin domain receptor function. Cell Signal. 2006;18:1108-1116.
44. Hou G, Vogel W, Bendeck MP. The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair. J Clin Invest. 2001;107:727-735.
45. Franco C, Hou G, Ahmad PJ, Fu EY, Koh L, Vogel WF, Bendeck M P. Discoidin domain receptor 1 (ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing infam-mation in low-density lipoprotein receptor-defcient mice. Circ Res. 2008;102:1202-1211.